Opposing Roles of S1P₃ Receptors in Myocardial Function

Area of Science:

• Cardiovascular Biology
• Pharmacology
• Molecular Medicine

Background:

• Sphingosine-1-phosphate (S1P) is a lipid mediator with complex effects on the heart.
• Previous studies suggest S1P can protect against ischemia/reperfusion (I/R) injury but also causes vasoconstriction.

Purpose of the Study:

• To differentiate the beneficial and harmful cardiac effects of S1P during I/R.
• To identify the specific S1P receptors and signaling pathways involved in these effects.

Main Methods:

• Utilized Langendorff-perfused wild type (WT), S1P receptor 2 knockout (S1P2-KO), and S1P receptor 3 knockout (S1P3-KO) murine hearts.
• Hearts were subjected to intravascular S1P administration, I/R, or a combination of both.

Main Results:

• S1P significantly reduced coronary flow (CF) in WT hearts, mediated primarily by the S1P3 receptor.
• S1P3 deficiency worsened cardiac functional recovery and increased infarct size post-I/R, indicating a cardioprotective role for S1P3.
• Pre-ischemic S1P exposure impaired cardiac performance and increased infarct size, despite S1P3 deficiency improving post-ischemic CF.

Conclusions:

• S1P receptor 3 (S1P3) exhibits a dual role, offering direct myocardial protection while also causing cardiosuppression via coronary vasoconstriction.
• In acute coronary syndromes, S1P may have competing effects on myocardial function due to S1P3 activation.